tiprankstipranks
Avacta Settles Bond Payment in Cash, On Track for 2024 Goals
Company Announcements

Avacta Settles Bond Payment in Cash, On Track for 2024 Goals

Avacta Group plc (GB:AVCT) has released an update.

Don't Miss Our Christmas Offers:

Avacta Group plc, a life sciences company focusing on cancer treatments and diagnostics, has announced the cash settlement of £3.13 million for the latest quarterly payment on its Convertible Bonds. This move, aimed at reducing potential shareholder dilution and considering the company’s financial health, lowers the bond principal to £33.15 million. Avacta also confirms that it is on target to meet its second half-year objectives for 2024, including updates on its AVA6000 clinical program.

For further insights into GB:AVCT stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskAvacta Group Opens Phase 1b Trial for Targeted Cancer Therapy
TipRanks UK Auto-Generated NewsdeskAvacta Group Advances with Targeted Cancer Therapies
TipRanks UK Auto-Generated NewsdeskAvacta Group Unveils Promising Cancer Therapy Advances
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App